Migragesic IDA Interactions
There are 457 drugs known to interact with Migragesic IDA (acetaminophen / dichloralphenazone / isometheptene mucate), along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 50 are major, 377 are moderate, and 30 are minor.
- View all 457 medications that may interact with Migragesic IDA
- View Migragesic IDA alcohol/food interactions (2)
- View Migragesic IDA disease interactions (7)
Most frequently checked interactions
View interaction reports for Migragesic IDA (acetaminophen / dichloralphenazone / isometheptene mucate) and the medicines listed below.
- Breo Ellipta (fluticasone / vilanterol)
- Calcium 600+D Plus Minerals (multivitamin with minerals)
- Centrum Silver (multivitamin with minerals)
- Clenia Foaming Wash (sulfacetamide sodium/sulfur topical)
- cyclobenzaprine
- Cymbalta (duloxetine)
- doxycycline
- Finacea (azelaic acid topical)
- hydrocodone
- Metoprolol Succinate ER (metoprolol)
- mupirocin topical
- omeprazole
- prazosin
- simvastatin
- tamsulosin
- topiramate
- Viagra (sildenafil)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Migragesic IDA alcohol/food interactions
There are 2 alcohol/food interactions with Migragesic IDA (acetaminophen / dichloralphenazone / isometheptene mucate).
Migragesic IDA disease interactions
There are 7 disease interactions with Migragesic IDA (acetaminophen / dichloralphenazone / isometheptene mucate) which include:
More about Migragesic IDA (acetaminophen / dichloralphenazone / isometheptene mucate)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimigraine agents
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.